Henri Bertrand

Title: Innovations of Henri Bertrand in Liposome Technology

Introduction

Henri Bertrand is a notable inventor based in Châtillon, France. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of liposome-based drug delivery systems. His innovative work focuses on enhancing the efficacy of heparin through advanced formulations.

Latest Patents

Henri Bertrand holds a patent for "Liposomes containing heparin and a process for obtaining them." This patent describes heparin-based preparations wherein heparin is retained in or on liposomes. The lipids used in these liposomes are primarily phospholipids that comprise acyl chains derived from non-saturated fatty acids, particularly essential fatty acids. These heparin-liposome preparations exhibit heparinic activity when administered in vivo via the oral route, demonstrating a delayed-type action. He has 1 patent to his name.

Career Highlights

Henri Bertrand has been associated with Choay, S.A., where he has applied his expertise in liposome technology to develop innovative pharmaceutical solutions. His work has contributed to advancements in drug delivery systems, making medications more effective and accessible.

Collaborations

Henri Bertrand has collaborated with Edgar Sache, working together to enhance the research and development of liposome formulations. Their partnership has been instrumental in pushing the boundaries of pharmaceutical innovations.

Conclusion

Henri Bertrand's contributions to liposome technology and heparin formulations highlight his role as a significant inventor in the pharmaceutical industry. His innovative approaches continue to influence the development of effective drug delivery systems.